Interventional device firm ev3 of Plymouth, MN, announced terms of its completed purchase of Redwood City, CA-based FoxHollow Technologies.
ev3 will issue 43.1 million shares of common stock and pay $81.8 million in cash pursuant to the merger. Each FoxHollow share electing stock in the merger will receive 1.62 shares of ev3 common stock, and each FoxHollow share electing cash in the merger will receive $21.42 per share in cash and 0.281 shares of ev3 common stock.
The company expects the transaction to be completed within the next several days.
By AuntMinnie.com staff writers
October 19, 2007
Related Reading
ev3 completes FoxHollow purchase, October 5, 2007
ev3 reports Q1 double-digit sales growth, secondary offering, April 3, 2007
ev3 gets FDA approval for Protege RX, January 25, 2007
ev3 stent gets FDA, CE nods for Protégé, March 10, 2006
ev3 stent gets 510(k), October 21, 2004
Copyright © 2007 AuntMinnie.com
